Anaphylaxis from intraperitoneal infusion of cisplatin -: A case report

被引:5
作者
Özgüroglu, M [1 ]
Demir, G [1 ]
Demirelli, F [1 ]
Mandel, NM [1 ]
机构
[1] Univ Istanbul, Cerrahpasa Med Sch, Dept Internal Med, Sect Med Oncol, Istanbul, Turkey
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1999年 / 22卷 / 02期
关键词
anaphylaxis; intraperitoneal chemotherapy; cisplatin;
D O I
10.1097/00000421-199904000-00013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anaphylactic reactions to platinum compounds and paclitaxel are well-recognized complications during their systemic administration. Although there have been reports describing anaphylaxis during intravesical instillation of chemotherapeutic agents, to the best of the authors' knowledge, no hypersensitivity reactions after intraperitoneal administration of chemotherapeutic drugs has been reported in the English literature. The authors report an unusual case of anaphylaxis occurring in a 33-year-old woman who has been treated with paclitaxel and cisplatin for ovarian cancer. She developed a hypersensitivity reaction during her ninth cycle of chemotherapy, immediately after institution of intraperitoneal infusion of cisplatin. it is important to be aware of the possibility of anaphylaxis during chemotherapy administration other than the systemic route go that appropriate premedication or effective treatment can be promptly instituted.
引用
收藏
页码:172 / 173
页数:2
相关论文
共 18 条
[2]  
BLUMENREICH MS, 1982, CANCER, V50, P863, DOI 10.1002/1097-0142(19820901)50:5<863::AID-CNCR2820500509>3.0.CO
[3]  
2-Q
[4]   Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles [J].
CiesielskiCarlucci, C ;
Leong, P ;
Jacobs, C .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04) :373-375
[5]  
DENIS L, 1983, LANCET, V1, P1378
[6]  
GOLDBERG A, 1994, ANN ALLERGY, V73, P271
[7]  
KHAN A, 1975, CANCER RES, V35, P2766
[8]  
MARKMAN M, 1984, LANCET, V2, P1164
[9]   PHASE-II TRIAL OF PACLITAXEL SHOWS ANTITUMOR-ACTIVITY IN PATIENTS WITH PREVIOUSLY TREATED GERM-CELL TUMORS [J].
MOTZER, RJ ;
BAJORIN, DF ;
SCHWARTZ, LH ;
HUTTER, HS ;
BOSL, GJ ;
SCHER, HI ;
LYN, P ;
FISCHER, P .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) :2277-2283
[10]  
ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1